<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03256513</url>
  </required_header>
  <id_info>
    <org_study_id>D161100003816002</org_study_id>
    <nct_id>NCT03256513</nct_id>
  </id_info>
  <brief_title>The Safety and Efficacy of Peri-procedure Blood Pressure Management of Revascularization</brief_title>
  <official_title>The Safety and Efficacy of Peri-procedure Blood Pressure Management of Revascularization for Ischemic Cerebral Vascular Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xuanwu Hospital, Beijing</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The 306 Hospital of People's Liberation Army</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Xuanwu Hospital, Beijing</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: Referring The relation between CEA(Carotid endarterectomy) postoperative blood
      flow monitoring and blood pressure, and combining patient demographics and preoperative risk
      factors to establish an applicable individual blood pressure controlling model. By comparing
      with routine antihypertensive strategies through prospective randomized controlled trials ,
      to provide the best perioperative blood pressure control standards and strategies for each
      patient ,thus better ensuring the safety and efficacy of CEA .
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 10, 2017</start_date>
  <completion_date type="Anticipated">June 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>death</measure>
    <time_frame>30 days</time_frame>
    <description>all cause death</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ischemic stroke</measure>
    <time_frame>30 days</time_frame>
    <description>Ischemic stroke is defined as an acute episode of neurological events with focal symptoms and signs, with a duration of more than 24h and confirmed by imaging.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>cardiovascular events</measure>
    <time_frame>30 days</time_frame>
    <description>Cardiovascular events were defined as: ECG presentation clearly different from preoperative myocardial ischemia, myocardial infarction, arrhythmia and cardiovascular death.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>transient ischemic attack,TIA</measure>
    <time_frame>30 days</time_frame>
    <description>transient ischemic attack, TIA is defined as: Patients with new onset of neurological symptoms and / or signs, duration &lt; 24 hours, MRI diffusion weighted imaging (DWI) did not find new infarcts. If MRI DWI showed new lesion, ischemic stroke was defined.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cerebral hemorrhage</measure>
    <time_frame>30 days</time_frame>
    <description>cerebral hemorrhage including intracerebral hemorrhage, epidural or subdural hemorrhage, subarachnoid hemorrhage.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hyperperfusion syndrome</measure>
    <time_frame>30 days</time_frame>
    <description>Hyperfusion Syndrome is defined as : 30 days after operation, new onset headache, vomiting, mental symptoms, macular edema, focal seizures, neurological dysfunction, or imaging brain edema, visible bleeding, and exception of new ischemic cerebral infarction or other causes.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>epilepsy</measure>
    <time_frame>30 days</time_frame>
    <description>epilepsy is defined as focal onset, with or without evolution to a bilateral tonic-clonic seizure, confirmed by EEG findings including interictal epileptiform discharges (IEDs), lateralized periodic discharges (LPDs; previously known as periodic lateralized epileptiform discharges [PLEDs]), and generalized periodic discharges (GPDs)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2270</enrollment>
  <condition>Cerebral Revascularization</condition>
  <condition>Ischemic Cerebrovascular Disease</condition>
  <arm_group>
    <arm_group_label>model controlling</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>an statistical model for periprocedural blood pressure control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional controlling</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>an conventional strategy for periprocedural blood pressure control</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>model controlling</intervention_name>
    <description>control blood pressure by statistical l model with anticipate lowest peri-procedure risk</description>
    <arm_group_label>model controlling</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>conventional controlling</intervention_name>
    <description>control blood pressure by conventional strategy</description>
    <arm_group_label>conventional controlling</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  symptomatic patient with carotid artery stenosis&gt;=50% or asymptomatic patient with
             carotid artery stenosis&gt;=70%, according to DSA or CTA;

          -  without massive cerebral infarction(infarction area &gt;1/2 territory of middle cerebral
             artery) confirmed by CT or MRI;

          -  informed consent acquired.

        Exclusion Criteria:

          -  lesion beyond range limit of procedure (higher than C2);

          -  target vascular complete occlusion or ipsilateral intracranial artery severe stenosis
             or complete occlusion cannot be revascularized via CEA procedure

          -  nonatherosclerotic carotid stenosis, such as vasculitis, dissection, congenital
             vascular malformation;

          -  history of instable angina pectoris, myocardial infarction or congestive heart failure
             within 6 months unable to accept systematic anesthesia;

          -  history of severe injury, surgery or radiotherapy on neck;

          -  with comorbid hemorrhagic cerebral disease such as intracranial aneurysm or vascular
             malformation;

          -  with comorbid blood system disease causing refractory coagulation dysfunction or
             rejection to blood or blood products perfusion;

          -  with other comorbidity, expected life &lt; 2 years;

          -  severe diabetes mellitus difficult to control, blood sugar &gt;300mg/dl;

          -  pregnancy or peri-natal period;

          -  intolerance to systematic anesthesia or surgery after adequate preparation.

          -  intolerance to peri-procedural drug possible to administrated;

          -  not cooperating or rejecting to informed consent;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liqun Jiao, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of neurosurgery, Xuanwu hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liqun Jiao, MD</last_name>
    <phone>86-10-83198899</phone>
    <phone_ext>8836</phone_ext>
    <email>jiaoliqun@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of neurosurgery, Xuanwu hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100053</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liqun Jiao, MD</last_name>
      <phone>86-10-83198899</phone>
      <phone_ext>8836</phone_ext>
      <email>jiaoliqun@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2017</study_first_submitted>
  <study_first_submitted_qc>August 17, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 22, 2017</study_first_posted>
  <last_update_submitted>August 17, 2017</last_update_submitted>
  <last_update_submitted_qc>August 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Xuanwu Hospital, Beijing</investigator_affiliation>
    <investigator_full_name>lingfeng</investigator_full_name>
    <investigator_title>clinical investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cerebrovascular Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

